Dr. Reddy's Laboratories
RDY
#1675
Rank
A$18.55 B
Marketcap
A$22.29
Share price
0.85%
Change (1 day)
-2.82%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): A$1.34 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are A$3.95 Billion. a decrease over its 2024 earnings that were of A$1.30 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 A$1.26 B-2.73%
2024 A$1.30 B7.01%
2023 A$1.21 B32.93%
2022 A$0.91 B26.77%
2021 A$0.72 B31.44%
2020 A$0.54 B54.54%
2019 A$0.35 B-12.26%
2018 A$0.40 B23.6%
2017 A$0.32 B4.47%
2016 A$0.31 B-55.7%
2015 A$0.70 B1.83%
2014 A$0.69 B-3.78%
2013 A$0.72 B54.07%
2012 A$0.46 B-16.23%
2011 A$0.55 B56.66%
2010 A$0.35 B-235.36%
2009 -A$0.27 Billion-198.53%
2008 A$0.26 B30.77%
2007 A$0.20 B-14.61%
2006 A$0.23 B703.63%
2005 A$29.84 M649.45%
2004 A$3.98 M-95.68%
2003 A$92.09 M-14.86%
2002 A$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.87 B 1,707.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$15.34 B 1,112.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.09 B 776.90%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
A$14.50 B 1,046.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$3.29 B 160.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel